INSULIN RESISTANCE IS A CHARACTERISTIC FEATURE OF PRIMARY HYPERTENSION INDEPENDENT OF OBESITY

被引:580
作者
POLLARE, T [1 ]
LITHELL, H [1 ]
BERNE, C [1 ]
机构
[1] UNIV UPPSALA,DEPT INTERNAL MED,S-75105 UPPSALA,SWEDEN
来源
METABOLISM-CLINICAL AND EXPERIMENTAL | 1990年 / 39卷 / 02期
关键词
D O I
10.1016/0026-0495(90)90071-J
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The relationship between abnormalities in carbohydrate metabolism and hypertension was studied in 143 newly detected hypertensive patients (59% obese) of both sexes (90 males, 53 females) and compared with 51 normotensive controls. Insulin-mediated glucose disposal assessed with the euglycemic insulin clamp technique was significantly decreased in both non-obese (7.2 ± 2.1 mg/kg/min; P < .05) and obese hypertensives (5.1 ± 2.1 mg/kg/min; P < .01) compared with the controls (8.4 ± 1.8 mg/kg/min). The decrease in insulin sensitivity and increase in basal insulin as well as a decreased rate of glucose disposal after an intravenous glucose tolerance test (IVGTT) were verified also after statistical adjustment for sex, age, body mass index, and waist-hip ratio. The insulin index (ratio between peak and basal insulin) during IVGTT was significantly decreased in the hypertensive patients (P < .001). After the statistical adjustment for the factors mentioned the following lipid abnormalities were still significant: total cholesterol (6.25 ± 1.12 mmol/L non-obese; 6.06 ± 1.20 mmol/L obese; 5.41 ± 1.02 mmol/L controls), triglycerides (1.70 ± 0.74 mmol/L nonobese; 2.26 ± 1.13 mmol/L obese; 1.24 ± 0.53 mmol/L controls) and free fatty acids (0.57 ± 0.20 mmol/L nonobese; 0.59 ± 0.20 mmol/L obese; 0.48 ± 0.15 mmol/L controls). This study shows that after correction for a series of probable confounding variables, hypertension emerges as part of a syndrome characterized by major abnormalities of carbohydrate, and lipid metabolism, which independently or in concert may act as important risk factors for cardiovascular disease. © 1990.
引用
收藏
页码:167 / 174
页数:8
相关论文
共 55 条
  • [1] BERGLUND G, 1976, ACTA MED SCAND, V200, P163
  • [2] ASSESSMENT OF INSULIN SENSITIVITY INVIVO
    BERGMAN, RN
    FINEGOOD, DT
    ADER, M
    [J]. ENDOCRINE REVIEWS, 1985, 6 (01) : 45 - 86
  • [3] RELATIONSHIP BETWEEN BLOOD-PRESSURE AND PLASMA-INSULIN IN NONOBESE AND OBESE NONDIABETIC SUBJECTS
    BONORA, E
    ZAVARONI, I
    ALPI, O
    PEZZAROSSA, A
    BRUSCHI, F
    DALLAGLIO, E
    GUERRA, L
    COSCELLI, C
    BUTTURINI, U
    [J]. DIABETOLOGIA, 1987, 30 (09) : 719 - 723
  • [4] THE EFFECT OF GROWTH-HORMONE ON GLUCOSE-METABOLISM AND INSULIN-SECRETION IN MAN
    BRATUSCHMARRAIN, PR
    SMITH, D
    DEFRONZO, RA
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1982, 55 (05) : 973 - 982
  • [5] BODY-MASS, BLOOD-PRESSURE, GLUCOSE, AND LIPIDS - DOES PLASMA-INSULIN EXPLAIN THEIR RELATIONSHIPS
    CAMBIEN, F
    WARNET, JM
    ESCHWEGE, E
    JACQUESON, A
    RICHARD, JL
    ROSSELIN, G
    [J]. ARTERIOSCLEROSIS, 1987, 7 (02): : 197 - 202
  • [6] CAMBIEN F, 1982, ADV DIABETES EPIDEMI, P189
  • [7] DIURNAL AND SEASONAL-VARIATION IN ORAL GLUCOSE-TOLERANCE - STUDIES IN ANTARCTIC
    CAMPBELL, IT
    JARRETT, RJ
    KEEN, H
    [J]. DIABETOLOGIA, 1975, 11 (02) : 139 - 145
  • [8] THE TRIGLYCERIDE ISSUE - A VIEW FROM FRAMINGHAM
    CASTELLI, WP
    [J]. AMERICAN HEART JOURNAL, 1986, 112 (02) : 432 - 437
  • [9] CEDERHOLM J, 1985, ACTA MED SCAND, V217, P363
  • [10] OVERWEIGHT AND HYPERTENSION - A REVIEW
    CHIANG, BN
    PERLMAN, LV
    EPSTEIN, FH
    [J]. CIRCULATION, 1969, 39 (03) : 403 - +